Literature DB >> 15816512

Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line.

Yongpeng Gu1, Kee-Hong Kim, Daejin Ko, Shiv Srivastava, Judd W Moul, David G McLeod, Johng S Rhim.   

Abstract

The generation of suitable in vitro models is critical for understanding the process associated with the development and progression of prostate cancer in high-risk African-American men. However, the generation of long-term human prostate epithelial cell lines derived from primary human prostate epithelium have been unsuccessful due to the absence of in vitro immortalization. We have successfully established an immortal human prostate epithelial cell line from primary benign tissues of African-American prostate cancer patients by using telomerase. The actively proliferating secondary African-American prostate epithelial RC-165N cells, derived from benign prostate tissue of a radical prostatectomy specimen, were transduced through infection with a retrovirus vector expressing the human telomerase catalytic subunit (hTERT). A high level of telomerase activity was detected in RC-165N/hTERT cells but not in RC-165N cells. RC-165N/hTERT cells are currently growing well at passage 50 whereas RC-165N cells senesced within passage 3. RC-165N/hTERT cells exhibit epithelial morphology. These immortalized cells showed no cell growth in soft agar, and no tumor formation in SCID mice. The RC-165N/hTERT cells express androgen-regulated prostate-specific homobox gene. NKX 3.1 and epithelial cell specific cytokeratin 8, androgen receptor (AR), prostate stem cell antigen and p16, but not PSA. AR protein was detected by Western blot analysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816512

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.

Authors:  Garrett Daniels; Yirong Li; Lan Lin Gellert; Albert Zhou; Jonathan Melamed; Xinyu Wu; Xinming Zhang; David Zhang; Daniel Meruelo; Susan K Logan; Ross Basch; Peng Lee
Journal:  Endocr Relat Cancer       Date:  2014-01-16       Impact factor: 5.678

2.  Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins.

Authors:  Jennifer S Myers; Karin A Vallega; Jason White; Kaixian Yu; Clayton C Yates; Qing-Xiang Amy Sang
Journal:  BMC Cancer       Date:  2017-07-11       Impact factor: 4.638

3.  MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1.

Authors:  Shaniece C Theodore; Melissa Davis; Fu Zhao; Honghe Wang; Dongquan Chen; Johng Rhim; Windy Dean-Colomb; Timothy Turner; Weidong Ji; Guohua Zeng; William Grizzle; Clayton Yates
Journal:  Oncotarget       Date:  2014-06-15

4.  Immortalization of human primary prostate epithelial cells via CRISPR inactivation of the CDKN2A locus and expression of telomerase.

Authors:  Ziran Zhao; Holly Fowle; Henkel Valentine; Zemin Liu; Yinfei Tan; Jianming Pei; Simone Badal; Joseph R Testa; Xavier Graña
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-09-01       Impact factor: 5.554

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.